$ Value
$0
Shares
16,000
Price
$0
Filed
Jun 2
Insider
Name
Jenkins John Kenneth
Title
—
CIK
0001742557
Roles
Transaction Details
Transaction Date
2025-05-30
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
16,000
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2024. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.21 to $7.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | On May 30, 2025, 4,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant. | This amount includes 4,800 unvested RSUs that were granted on May 30, 2025. | The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.
Filing Info
Jenkins John Kenneth's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-05-30 | CRBP | ▼ | $20K |
| 2025-05-30 | CRBP | A | $0 |
| 2025-05-30 | CRBP | A | $0 |
Other Insiders at CRBP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Moran Sean F.
Chief Financial Officer
|
— | $37K | 2026-02-13 |
|
Cohen Yuval
Chief Executive Officer
|
— | $108K | 2026-02-13 |
|
Smethurst Dominic
Chief Medical Officer
|
— | $77K | 2026-03-02 |
|
Hodgson Ian
Chief Operating Officer
|
— | $26K | 2026-02-17 |